Actively Recruiting
Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
Led by ScreenCell · Updated on 2026-04-24
93
Participants Needed
1
Research Sites
92 weeks
Total Duration
On this page
Sponsors
S
ScreenCell
Lead Sponsor
A
AXELYS SANTE
Collaborating Sponsor
AI-Summary
What this Trial Is About
Liquid biopsy is a noninvasive method for detecting and quantifying circulating tumor cells (CTCs). Thanks to ScreenCell technology, this study aims to evaluate the evolution of the number of CTCs during breast cancer follow-up. The identification and characterization of CTCs would make it possible to obtain information on the stage and molecular characteristics of cancer during follow-up
CONDITIONS
Official Title
Evaluation of Circulating Tumor Cells (CTC) Relevance in Breast Cancer Follow-up Using the ScreenCell Device
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged 18 years or older
- For metastatic breast cancer patients: diagnosed with metastatic breast cancer at inclusion or metastatic relapse requiring therapy change
- For non-metastatic invasive breast cancer patients: diagnosed with non-metastatic invasive breast cancer and no prior treatment
- For healthy volunteers: no cancer history and negative mammogram within 2 years before inclusion
You will not qualify if you...
- Male
- Under 18 years old
- Refusal to participate or withdrawal of consent
- Pregnant or breastfeeding women
- Diagnosis of any cancer other than breast cancer during follow-up
- For healthy volunteers: history of cancer or positive circulating tumor cells detected during screening
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CMC Ambroise Paré Hartmann
Neuilly-sur-Seine, France, 92200
Actively Recruiting
Research Team
J
Jessica GROULT, Ph.D
CONTACT
S
Sina NASERIAN, Ph.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here